<DOC>
	<DOCNO>NCT00711477</DOCNO>
	<brief_summary>The purpose study assess effect naltrexone SR/bupropion SR ( NB ) brain function response food cue use functional magnetic resonance image overweight obese subject .</brief_summary>
	<brief_title>A Study Using Functional Magnetic Resonance Imaging ( fMRI ) Assess Effects Naltrexone SR/ Bupropion SR Therapy Overweight Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Righthanded , female subject , 18 45 year age Body mass index ( BMI ) ≥ 27 ≤ 40 kg/m² Free clinically significant illness disease determine medical history physical examination Able provide proof identity enrollment process In good general health , without clinically significant medical history , physical examination finding laboratory result Laboratory value obtain within 30 day study entry within normal range healthy volunteer . Normal urinalysis initial screen day define : negative glucose , negative trace protein , negative trace hemoglobin Normotensive ( systolic ≤140 mm Hg , diastolic ≤90 mm hg ) On concomitant medication exception oral contraceptive , vitamin , counter pain , indigestion allergy medication All woman child bear potential must nonlactating , must negative STAT pregnancy test , agree use effective contraception method throughout study period 30 day discontinuation study drug . The following consider effective method contraception : Combination progestinonly birth control pill ( oral contraceptive ) , vaginal contraceptive ring , contraceptive patch , Depo Provera , intrauterine device , barrier method spermicide ( condom/foam , diaphragm/ spermicide ) , abstinence . ( Subjects tubal ligation , hysterectomy postmenopausal 2 year consider NOT child bear potential ) For woman use hormonal method contraception , follicular phase menstrual cycle baseline visit . Nonsmoker use tobacco nicotine product least 6 month prior baseline . On screen study day , test subject ' urine presence nicotinine/cotinine ( STAT ) test confirmatory evidence nonsmoker addition selfreport . A Tobacco Questionnaire Breath CO also administer eligibility day screen confirmation purpose . No clinically significant abnormality ECG , baseline QTc &lt; 470 Able comply require study procedure Available follow duration study Willing able give write informed consent Obesity know endocrine genetic origin ( e.g. , untreated hypothyroidism , Cushing 's syndrome , Prader Willi Syndrome , establish Polycystic Ovary Syndrome ) Inability participate fMRI scan session History occupational exposure metal flake body eye . History known indwell ferromagnetic metal fragment . History acute chronic illness require medical therapy include active gastrointestinal condition might interfere drug absorption History presence hepatic , renal , cardiovascular gastrointestinal disease Type I Type II diabetes mellitus require pharmacotherapy Active malignancy history malignancy ( nonmelanoma skin cancer surgically cure cervical cancer ) within 5 year enrollment Serious psychiatric illness , include lifetime history psychiatric hospitalization , suicide attempt , bipolar disorder , schizophrenia psychosis , bulimia , anorexia nervosa ; current serious personality disorder , ( e.g . borderline antisocial ) , major depressive disorder within previous two year , suicidal ideation need psychiatric treatment previous 6 month . In need medication treatment psychiatric disorder within previous 6 month prior randomization . IDSSR total score &gt; 25 score &gt; 1 item 5 ( sadness ) , 6 ( irritability ) , 7 ( anxiety/tension ) 18 ( suicidality ) History alcohol drug abuse , current within 2 year Unable abstain caffeinated product consumption least 48 hour History surgical intervention obesity Use drug , herb , dietary supplement believe significantly affect body weight participation weight loss management program within one month prior randomization . History hypersensitivity bupropion naltrexone History seizure disorder predisposition seizure ( e.g. , history cerebrovascular accident , brain surgery , head trauma ≥5 minute loss consciousness , concussion symptom last ≥ 15 minute , skull fracture , subdural hematoma , febrile seizure ) need therapy anticonvulsant medication . History treatment bupropion naltrexone within 12 month Positive urine drug screen STAT test perform day study . Pregnant breastfeeding Planned surgical procedure trip impact conduct study Use investigational drug , device procedure within 30 day Any condition opinion investigator make subject unsuitable inclusion study Participation previous clinical trial sponsor Orexigen Therapeutics . Study personnel , sponsor representative immediate family .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>obesity</keyword>
	<keyword>overweight</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>naltrexone</keyword>
	<keyword>bupropion</keyword>
</DOC>